title: Management of HIV in the pregnant woman.
abstract: The treatment of human immunodeficiency virus (HIV)-infected pregnant women is one of the most effective HIV-prevention interventions known. With prenatal testing, antiviral therapy, scheduled cesarean section when indicated, and formula feeding when feasible, rates of neonatal and perinatal HIV infection can diminish significantly. Although significant prevention is achievable, new cases of HIV in neonates continue to occur both worldwide and locally due to limited resources, delayed diagnosis, lack of linkage to care, and lack of timely effective therapy. Where those resources are available, the management of HIV infection in the pregnant woman requires a multidisciplinary expert approach to achieve optimal outcomes for both mother and child.
authors.affiliation: Division of Infectious Diseases, The Ohio State University, Columbus, Ohio, USA. john.davis@osumc.edu
authors.forename: John A
authors.initials: JA
authors.lastname: Davis
authors.forename: Sigal
authors.initials: S
authors.lastname: Yawetz
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D001942:Breast Feeding; D018791:CD4 Lymphocyte Count; D002585:Cesarean Section; D000075202:Contraindications; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D007743:Labor, Obstetric; D011181:Postnatal Care; D016742:Preconception Care; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000188:drug therapy*; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents